Medi Assist Healthcare Services has received a BUY rating from a broker with a target price of ₹477, indicating a 45% upside potential from the current market price of ₹338.15. According to reports from The Hindu BusinessLine, the broker has initiated coverage on the company, highlighting its position as India's largest health insurance third-party administrator (TPA).
The company has demonstrated robust financial growth with its premium under management compounding at a 27% CAGR since FY21 to ₹25,923 crore, significantly outperforming the industry every year. As reported by The Hindu BusinessLine, Medi Assist Healthcare Services operates the claims and benefits infrastructure that serves as the backbone between insurers, hospitals and policyholders. The company adjudicates claims, manages a 20,000-hospital cashless network, runs fraud detection and administers government health schemes while earning fees as a percentage of premium administered.
The group segment represents 69.5% of FY26 revenue, with the company maintaining a group market share of 33.7% (+340 bps year on year), approximately five times its nearest competitor. According to the broker's analysis, this dominant position in the group segment provides significant competitive advantages in the health insurance administration market.
While FY26 operating revenue grew 25.1% to ₹904.8 crore, the EBITDA margin fell 201 bps to 19.3% due to the consolidation of Paramount TPA. However, as reported by The Hindu BusinessLine, the quarterly margin has shown recovery, improving from 17.1% in Q2FY26 to 20.3% in Q1FY27. The broker expects the current challenges to be temporary, with the company's franchise adding 340 bps of group share and maintaining a debt-free balance sheet.
The broker has assigned a multiple of 22 at an EPS of 21.7 for the target price of ₹477, representing the 45% upside potential from current levels. According to the broker's analysis, FY26 represents a trough rather than a trend, with identifiable challenges expected to roll off together in FY27. The company's strong market position, consistent growth trajectory, and debt-free balance sheet support the positive investment outlook for Medi Assist Healthcare Services.
